Health & Medical · Week of Nov 2, 2026
Q3 earnings and guidance updates: the week in health releases
Third-quarter results from Waters, Trulieve and Syra Health led the week, alongside a board change, a flood closure and a Parkinson's education effort.
Earnings drove much of the week's news. Waters Corporation reported third quarter 2026 revenue of $1.767 billion, raised its full-year guidance and announced the acquisition of MOBILion Systems. Trulieve Cannabis Corp. reported revenue down 20% to $230 million but a return to net income, and Syra Health said it posted its third consecutive profitable quarter on record revenue of $2,557,295. Encompass Health reaffirmed its full-year guidance after flooding closed a Florida rehabilitation hospital.
Outside of results, several releases touched on how care is paid for and delivered. DarioHealth named John R. Palumbo chairman, citing the convergence of consumer-directed and payer-funded care, and Syra Health said it is recruiting Accountable Care Organizations after CMS approval of Syrenity for the ACCESS Model. Medtronic and The Michael J. Fox Foundation launched an educational initiative on deep brain stimulation, and Elanco Animal Health released survey data on pet owners' spending.
Waters Corporation
Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results
Waters Corporation reported third quarter 2026 revenue of $1.767 billion, including $871 million of organic revenue, and adjusted EPS up 21% to $4.10, while GAAP diluted EPS fell to $0.82 on acquisition-related charges. The company raised full-year revenue guidance to $6.479 billion to $6.497 billion and said it has acquired MOBILion Systems, a developer of SLIM high-resolution ion mobility separation technology.
Trulieve Cannabis Corp.
Trulieve Reports Third Quarter 2026 Results
Trulieve Cannabis Corp. reported third quarter 2026 revenue of $230 million, down 20% from $288 million, with net income attributable to common shareholders of $1 million versus a $27 million loss a year earlier; results reflect only medical operations after the June 3, 2026 deconsolidation of Harvest. The company says it received final DEA registrations for state licensed medical marijuana dispensaries and repaid $65 million of mortgage notes ahead of their 2028 maturity.
Syra Health
Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin
Syra Health reported Q3 2026 revenue up 52% to $2,557,295 and net income of $344,610, which it says marks its third consecutive profitable quarter, with gross margin rising to 46.3% from 32.9%. Following CMS approval of Syrenity for the ACCESS Model, the company says it is recruiting Accountable Care Organizations to use Syrenity with partner HealthSync.
DarioHealth Corp.
Dario Names Veteran Healthcare Executive John R. Palumbo Chairman of the Board as Company Positions Itself to Lead the Convergence of Consumer and Payer-Funded Care
DarioHealth Corp. appointed John R. Palumbo, a board member since April 2026 with more than 40 years of healthcare operating experience, as Chairman effective November 3, 2026, succeeding Yoav Shaked, who remains a director. The company says more than 80% of its contracted and late-stage annual recurring revenue is multi-condition, and Mr. Palumbo will join its November 12, 2026 earnings call.
Encompass Health Corp.
Encompass Health announces indefinite closure of Sea Pines Rehabilitation Hospital due to flood damage
Encompass Health said the 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, is closed indefinitely after Nov. 1-2, 2026 flooding, with all patients safely evacuated and all employees accounted for. The company reaffirmed full-year 2026 guidance of $6,450 million to $6,500 million in net operating revenue; Sea Pines contributed approximately $44 million in revenue and $14 million in Adjusted EBITDA in the first nine months of 2026.
Medtronic plc
Medtronic and Michael J. Fox Foundation Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
Medtronic plc and The Michael J. Fox Foundation announced an educational initiative on deep brain stimulation for people with Parkinson's and their caregivers, with resources available at michaeljfox.org/dbs as of Nov. 4, 2026. Medtronic is premier partner and funder, while MJFF says it maintains editorial oversight of the materials.
The Michael J. Fox Foundation for Parkinson's Research; Medtronic
Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
In its own release on the same initiative, The Michael J. Fox Foundation said the Medtronic-supported materials cover how DBS works, potential benefits and risks, surgery preparation and life with a DBS device. MJFF says it has funded more than $29 million in DBS research for Parkinson's since 2000.
Elanco Animal Health
October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority
Elanco Animal Health released an October 16-21, 2026 online survey of 2,018 U.S. adults in which 93% of pet owners said they maintained or increased pet spending over the past three months, and 7% said they would cut pet health spending under economic pressure. The survey found 38% of pet owners have shifted medication purchasing outside the clinic in the past year or two, with a doctor's recommendation cited as the top reason to switch medications.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Major Health News reporting.